GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial

Citation

Tian, D, Bennett, S, Coupland, L et al. 2019, 'GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial', Pharmacology Research & Perspectives , vol. 7, no. 6, pp. -.

Year

2019

Fields of Research

  • Clinical Pharmacy And Pharmacy Practice
  • Chemotherapy
  • Haematological Tumours

Updated:  07 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers